Zealand's stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the 'weight loss Olympics'

Thread starter International: Top News And Analysis
Start date Mar 6, 2026

International: Top News And Analysis

Guest

Mar 6, 2026

Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% weight-loss over 42 weeks.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Zealand's stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the 'weight loss Olympics'

Prefix: N/A

Forum: World News

Start date: Mar 6, 2026

Last reply date: Mar 6, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Mar 6, 2026

Replies: 0

Views: 10

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search